Astrazeneca

FromAstraZeneca ([email protected])
Subject (48)Tagrisso approved in Japan for early lung cancer
Preheader (107)Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Typography
Arial
Colors
Text Analysis
Body Words219
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px744 px
X-Spam Score1.0
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeOvernight

Tagrisso approved in Japan for early lung cancer

Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Tagrisso approved in Japan for early lung cancer